Table 3.
Variables | Exercise group | Dopamine agonists group | Placebo group |
---|---|---|---|
STS- 5 (sec) |
|
|
|
Baseline |
10.12±2.56 |
8.89±0.74 |
9.69±0.46 |
6-m post |
8.24±2.34† |
8.48±1.72 |
8.81±0.66 |
Δ Change |
−1.75±2.32 |
- 0.41±1.63 |
- 0.88±0.76 |
95% CI of Δ change |
−3.03 to −0.47 |
−1.91 to 1.09 |
−1.58 to −0.18 |
STS-30 (rep) |
|
|
|
Baseline |
14.73±4.00 |
14.83±2.13 |
14.75±0.9 |
6-m post |
17.84± 4.68† |
14.50±2.58 |
17.25±3.2 |
Δ Change |
2.96±4.87 |
- 0.33±2.33 |
2.50±2.51 |
95% CI of Δ change |
5.65 to 0.27 |
−0.63 to −0.03 |
4.81 to −0.19 |
STS-60 (rep) |
|
|
|
Baseline |
27.95±8.38 |
26.60±3.64 |
30.0±3.16 |
6-m post |
32.50±9.34 |
27.40±7.40 |
32.0±5.35 |
Δ Change |
4.26±8.23 |
0.80±4.65 |
2.00±3.26 |
95% CI of Δ change |
8.77 to −0.25 |
5.09 to −3.49 |
5.0 to −1.0 |
Normal Walk (sec) |
|
|
|
Baseline |
6.09±1.24 |
5.69±1.53 |
5.30±1.06 |
6-m post |
5.81±1.49 |
6.14±1.63 |
5.38±1.09 |
Δ Change |
−0.42±1.36 |
0.44±1.46 |
0.07±0.27 |
95% CI of Δ change |
−1.17 to 0.33 |
1.78 to −0.90 |
0.31 to −0.17 |
Fast Walk (sec) |
|
|
|
Baseline |
3.86±0.66 |
3.57±0.40 |
3.77±0.47 |
6-m post |
3.65±0.75 |
3.56±0.40 |
3.57±0.41 |
Δ Change |
−0.28±0.65 |
- 0.01±0.19 |
- 0.19±0.40 |
95% CI of Δ change |
−0.63 to 0.07 |
−0.18 to 0.16 |
−0.55 to 0.17 |
NSRI test (sec) |
|
|
|
Baseline |
84.46±21.35 |
70.10±20.46 |
52.48±14.24 |
6-m post |
75.02±26.60† |
67.68±20.78 |
53.44±17.13 |
Δ Change |
−9.25±13.41 |
−2.41±6.52 |
0.96±4.01 |
95% CI of Δ change | −16.6 to −1.85 | −8.41 to 3.59 | 4.65 to −2.73 |
All data are mean ± SD. Abbreviations: STS-5 Sit-to- stand test 5-repetitions, STS-60 Sit-to- stand test 60 seconds, STS-30 Repetitions’ measurement at 30 seconds as part of the STS-60 test, NSRI North staffordshire royal infirmary test.
†Significantly different from the respective baseline value.